bpc-157 clinicaltrials.gov nct

bpc-157 clinicaltrials.gov nct Human trials exploring anti-aging medicines Cachexia, the muscle-wasting syndrome that

Name: bpc-157 clinicaltrials.gov nct Human trials exploring anti-aging medicines Cachexia, the muscle-wasting syndrome that
Brand: lagence-mr.com
SKU: 72014299585
Price: 22.65 USD
Availability: InStock
Rating: 4.2358 (9 reviews)

Cachexia, the muscle wasting syndrome that affects 80% of cancer patients, has long been considered untreatable. For pancreatic cancer patients, it's one of the most devastating parts of the disease, and there are Australian Clinical Trials tm267368d1_6kimg023.jpg Drug delivery to the inflamed intestinal mucosa targeting technologies and human cell culture models for better therapies of IBD ScienceDirect Tyrosine Kinase Inhibitor Lenvatinib Based Nano Formulations and Cutting Edge Scale Up Technologies in revolutionizing Cancer Therapy ACS Applied Bio Materials

SKU: 72014299585 · From lagence-mr.com

4.2

USD22.65 USD72.65

Pay in 4 interest-free payments of $5.66 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 14 - Sep 19

Description

Current research has not identified a specific membrane receptor exclusively responsible for BPC-157's effects, suggesting the peptide may interact with various signaling systems or function through novel mechanisms not yet fully characterized

This product is supplied exclusively for research purposes and must be used in accordance with laboratory safety and compliance standards

[Google Scholar] 48

In animals, BPC 157 has an anti-inflammatory effect and therapeutic effects in functional recovery and the rescue of somatosensory neurons in the sciatic nerve after transection, upon brain injury after concussive trauma, and in severe encephalopathies